Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

"We're still in discussions with the (UK) government to figure out what type of incentives there may be. We don't have ...

The UK Government recently announced a new public-private collaboration to develop the world's first early warning system for ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Topical Drug ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

The news: Audi has just launched a new EV brand in China, and the company is making a bold branding move to set the vehicles ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Executed global exclusive development and commercialization license agreement with Novartis to advance VAV1-directed molecular ... Jefferies London Healthcare Conference (London, UK) – November 19, ...

ZURICH (Reuters) - Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan ...

DelveInsight's Dry Eye Disease Treatment Market Insights report provides the current and forecast market analysis, individual ...